Replies to post #114745 on Biotech Values

[jbog]

Dew,

For that to happen, generic Copaxone would have to still be unapproved five years from now (#msg-59789214). Possible but not likely, IMO.

I don't think it's likely either. But let's not forget that with where Teva has the pricing today, once they do get approval they can easily retake whatever generic program there is.